GlassScriptPhysician profile
Brittany Corrigan
NPI 1497137129
$783.13
in general payments reported to CMS, 2019-2025
12 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.74 · 2021: $18.32 · 2022: $50.96 · 2023: $81.40 · 2024: $381 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $268.20 | 2024 | Qelbree |
| Boston Scientific Corporation | $108.61 | 2025 | Intracept |
| Corium, LLC | $94.40 | 2024-2025 | Azstarys |
| Sanofi Pasteur INC. | $82.15 | 2022-2023 | |
| Cranial Technologies, INC | $41.96 | 2019 | |
| Merck Sharp & Dohme LLC | $41.40 | 2019-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Biomarin Pharmaceutical INC. | $37.78 | 2024-2025 | Voxzogo 1.2mg |
| Glaxosmithkline, LLC. | $35.38 | 2022-2024 | Bexsero |
| Ironshore Pharmaceuticals INC. | $23.41 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.32 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $17.04 | 2025 | Imcivree |
| Astrazeneca Pharmaceuticals LP | $14.48 | 2023 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Corrigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.